3 completed, 1 recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
Follow Nicole Fram M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal Cataract extraction with phacoemulsification comparing two systems - Nuclear Sclerosis of the Lens, Phacoemulsification Cataract Surgery | Not applicable | Recruiting | Nicole Fram M.D. | 30 | 2026-02-13 | 2026-03-18 |
| Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp, Prolensa 0.07% Ophthalmic Solution - Corneal Edema, Corneal Defect | Phase 4 | Completed | Nicole Fram M.D. | 50 | 2023-06-01 | 2026-02-20 |
| A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery Dextenza 0.4Mg Ophthalmic Insert - Anterior Chamber Inflammation, Ocular Pain | Completed | Nicole Fram M.D. | 25 | 2021-03-09 | 2021-07-26 | |
| Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp - Corneal Edema, Corneal Defect | Phase 4 | Completed | Nicole Fram M.D. | 36 | 2020-10-16 | 2023-07-24 |
Corneal Edema (3) · Eye Pain (3) · Cataract (1) · Cataract, Age-Related Nuclear (1) · Macular Edema (1)
Calcium Dobesilate (3) · Dexamethasone (2) · prednisolone acetate (2) · Cataract Extraction (1) · Methylprednisolone (1) · Ophthalmic Solutions (1) · bromfenac (1)
United States (4)
Nicole R Fram, M.D. (3) · Nicole Fram, MD (1)